Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Baric

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Ebiomedicine|November 14, 2022
Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronavirusesPeter J Halfmann, Steven J Frey, Kathryn Loeffler, et al.
Nature Communications|June 29, 2024
A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccinesJimin Lee, Cameron Stewart, Alexandra Schäfer, et al.
FEMS Microbiology Reviews|August 18, 2023
Praemonitus praemunitus: can we forecast and prepare for future viral disease outbreaks?Zoe Sessions, Tesia Bobrowski, Holli-Joi Martin, et al.
Viruses|September 23, 2022
Norovirus Infection in Young Nicaraguan Children Induces Durable and Genotype-Specific Antibody ImmunityPaul D Brewer-Jensen, Yaoska Reyes, Sylvia Becker-Dreps, et al.
Journal of Virology|December 30, 2016
Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and VaccinationUsha K Nivarthi, Nurgun Kose, Gopal Sapparapu, et al.
Science (New York, N.Y.)|February 19, 2026
Mucosal vaccination in mice provides protection from diverse respiratory threatsHaibo Zhang, Katharine Floyd, Zhuoqing Fang, et al.
Research Square|November 16, 2022
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive protection across divergent subgroupsGeoffrey Hutchinson, Olubukola Abiona, Cynthia Ziwawo, et al.
Research Square|September 30, 2020
Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801Angela Wahl, Lisa Gralinski, Claire Johnson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Molnupiravir, an Oral Antiviral Treatment for COVID-19William Fischer, Joseph J Eron, Wayne Holman, et al.
BMC Systems Biology|July 31, 2013
Specific mutations in H5N1 mainly impact the magnitude and velocity of the host response in miceNicolas Tchitchek, Amie J Eisfeld, Jennifer Tisoncik-Go, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Ebiomedicine|November 14, 2022
Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronavirusesPeter J Halfmann, Steven J Frey, Kathryn Loeffler, et al.
Nature Communications|June 29, 2024
A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccinesJimin Lee, Cameron Stewart, Alexandra Schäfer, et al.
FEMS Microbiology Reviews|August 18, 2023
Praemonitus praemunitus: can we forecast and prepare for future viral disease outbreaks?Zoe Sessions, Tesia Bobrowski, Holli-Joi Martin, et al.
Viruses|September 23, 2022
Norovirus Infection in Young Nicaraguan Children Induces Durable and Genotype-Specific Antibody ImmunityPaul D Brewer-Jensen, Yaoska Reyes, Sylvia Becker-Dreps, et al.
Journal of Virology|December 30, 2016
Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and VaccinationUsha K Nivarthi, Nurgun Kose, Gopal Sapparapu, et al.
Science (New York, N.Y.)|February 19, 2026
Mucosal vaccination in mice provides protection from diverse respiratory threatsHaibo Zhang, Katharine Floyd, Zhuoqing Fang, et al.
Research Square|November 16, 2022
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive protection across divergent subgroupsGeoffrey Hutchinson, Olubukola Abiona, Cynthia Ziwawo, et al.
Research Square|September 30, 2020
Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801Angela Wahl, Lisa Gralinski, Claire Johnson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Molnupiravir, an Oral Antiviral Treatment for COVID-19William Fischer, Joseph J Eron, Wayne Holman, et al.
BMC Systems Biology|July 31, 2013
Specific mutations in H5N1 mainly impact the magnitude and velocity of the host response in miceNicolas Tchitchek, Amie J Eisfeld, Jennifer Tisoncik-Go, et al.
Pageof 8